BioForm Medical to Announce Financial Results for Quarter and Fiscal Year Ended June 30, 2008, and Host Conference Call and Webcast on September 4, 2008

    SAN MATEO, Calif., Aug. 22 /EMWNews/ -- BioForm Medical,

Inc. (Nasdaq: BFRM) announced that on Thursday, September 4, 2008, it will

report its financial results for its fourth quarter and fiscal year ended

June 30, 2008. The Company will issue the earnings press release after the

NASDAQ Global Market closes and will hold a conference call with investors

at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).



    BioForm Medical Chief Executive Officer Steve Basta and Chief Financial

Officer Derek Bertocci will discuss the Company's results for the fourth

quarter and fiscal year ended June 30, 2008. The conference call will be

webcast live on the Investor Relations section of BioForm Medical's website

at http://www.bioform.com. The online archive of the broadcast will be

available approximately 90 minutes after the live call and will continue to

be available for four weeks.



    The conference call may be accessed by dialing 888-287-5530 for callers

in the U.S. and 719-785-1768 for international callers. Please notify the

operator that you would like to join "BioForm Medical's Fourth Quarter &

Fiscal 2008 Earnings Call" and provide the participant code "2257477", if

prompted.

    About BioForm Medical, Inc.:



    BioForm Medical, Inc. is a medical aesthetics company headquartered in

San Mateo, California, developing products that enhance aesthetic

procedures performed in dermatology and plastic surgery practices. BioForm

Medical's lead product is Radiesse(R) dermal filler, a long-lasting filler

for use in facial aesthetics. BioForm Medical is developing several future

aesthetics products, including a radiofrequency treatment to reduce nerve

function in the forehead, a sclerotherapy treatment for spider veins, and a

surgical adhesive for brow lifts. For more information about BioForm,

please visit http://www.bioform.com.








     Contact:

           Adam Gridley

           650.286.4025

           Vice President, Corporate Development

           BioForm Medical, Inc.